Initial treatment of Parkinson disease: levodopa or dopamine agonists

Arch Neurol. 2004 Dec;61(12):1966-9. doi: 10.1001/archneur.61.12.1966.
No abstract available

Publication types

  • Review

MeSH terms

  • Disease Management
  • Dopamine Agonists / therapeutic use*
  • Humans
  • Levodopa / therapeutic use*
  • Neuroprotective Agents / therapeutic use
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism

Substances

  • Dopamine Agonists
  • Neuroprotective Agents
  • Levodopa